지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2017.3
- 수록면
- 93 - 111 (19page)
이용수
초록· 키워드
오류제보하기
Objectives: The aim of this study is to make evidence-based data for developing a traditional Korean medicine clinical practice guideline for acute bronchitis.
Methods: We searched 3 international databases(PubMed, EMBASE, CENTRAL) and 7 domestic databases (KoreaMed, Kmbase, NDSL, KISS, KISTI, OASIS, KoreaTK) to identify randomized controlled trials (RCTs) of acute bronchitis using medicine in recent 10 years. The chosen trials were analyzed by their study design, age range, intervention group, control group, primary and second outcome measure, inclusion and exclusion of participants and adverse events.
Results: 15 RCTs are finally included in this study and most of their medications are herbal medicine. For diagnosis and outcome measure of acute bronchitis, Bronchitis Severity Score(BSS) was mostly used. Other measurements eligible are coughing fits, quality of life scale, sputum viscosity, change of individual symptoms and patient’s satisfaction. Test duration was for average 7days and safety assessment was held by recording adverse events. Except for anti-inflammatory and antibiotic trials, all medications are found to be effective and well-tolerated. General risk of bias of chosen trials is evaluated low.
Conclusions: A well designed clinical trials for traditional Korean medicine of acute bronchitis is needed and this study is expected to make it available.
Methods: We searched 3 international databases(PubMed, EMBASE, CENTRAL) and 7 domestic databases (KoreaMed, Kmbase, NDSL, KISS, KISTI, OASIS, KoreaTK) to identify randomized controlled trials (RCTs) of acute bronchitis using medicine in recent 10 years. The chosen trials were analyzed by their study design, age range, intervention group, control group, primary and second outcome measure, inclusion and exclusion of participants and adverse events.
Results: 15 RCTs are finally included in this study and most of their medications are herbal medicine. For diagnosis and outcome measure of acute bronchitis, Bronchitis Severity Score(BSS) was mostly used. Other measurements eligible are coughing fits, quality of life scale, sputum viscosity, change of individual symptoms and patient’s satisfaction. Test duration was for average 7days and safety assessment was held by recording adverse events. Except for anti-inflammatory and antibiotic trials, all medications are found to be effective and well-tolerated. General risk of bias of chosen trials is evaluated low.
Conclusions: A well designed clinical trials for traditional Korean medicine of acute bronchitis is needed and this study is expected to make it available.
목차
서론
대상 및 방법
결과
고찰
참고문헌
참고문헌 (43)
참고문헌 신청
2016 Statistical Indicator of Medical Expenses. Health Insurance Review & Assessment service. 2017:1-16.
Mudarri DH. Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US. Journal of Environmental and Public Health. 2016;2016:2386596.
Eom SJ. Essentials of Primary Care: Respiratory: The most common disease of Koreans, Acute bronchitis. The Korean Association of International Medicine Sping Conference Collection. 2016; 2016:122-5.
Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician. 2010;82(11): 1345-50.
Pratter MR. Cough and the common cold: ACCP evidence-based clinical practice guidelines. Chest 2006;129:72S-4S.
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
급·만성 기관지염과 알레르기성 비염의 국내 의료 이용 현황 분석
대한한의학회지
2019 .09
-
導赤降氣湯을 투여한 급성기관지염 치험 3례
대한한방내과학회지
2018 .01
-
Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea
Journal of Korean Medical Science
2015 .01
-
건선 한약제제 임상시험 가이드라인 개발을 위한 관련 국내외가이드라인과 기존 건선치료 한약제제 연구와의 비교
한방안이비인후피부과학회지
2016 .01
-
간암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
대한한방내과학회지
2019 .01
-
Clinical Trial
대한임상종양학회 학술대회지
2015 .02
-
한약에 대한 N-of-1 임상시험의 현황 – 문헌 고찰
대한한의학회지
2020 .03
-
한의약 의료기기 임상시험 교육 프로그램 개발을 위한 설문조사 연구
대한한의학회지
2015 .09
-
건선 치료용 한약제제에 대한 임상시험 가이드라인 설명 및 제언
한방안이비인후피부과학회지
2018 .01
-
폐암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
대한한의학회지
2019 .03
-
한약 임상시험의 특성 : 질병관리본부 임상연구정보서비스(CRIS)를 중심으로
대한한방내과학회지
2020 .01
-
감기 임상시험 가이드라인 제정을 위한 최신 임상시험 연구 분석
대한한방내과학회지
2016 .01
-
결장직장암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 대조군 임상시험 고찰
대한한의학회지
2019 .03
-
Important things to improve the quality of clinical trials
대한임상종양학회 학술대회지
2022 .02
-
암 환자의 항암제 임상시험에 대한 인식과 만족도
Asian Oncology Nursing
2019 .03
-
임상시험용 의약품 복약지도 항목에 대한 임상시험대상자 및 연구자의 요구도 조사
병원약사회지
2017 .01
-
소아 기능성 위장 장애의 한약 치료에 대한 임상연구 동향 - 중의학 무작위 대조군 임상시험을 중심으로
대한한방소아과학회지
2021 .08
-
Current Status and Challenges of Cancer Clinical Trials in Korea
Cancer Research and Treatment
2016 .01
-
소아암의 한의약치료 임상 동향 ? 대조군 임상연구를 중심으로
대한예방한의학회지
2020 .01
-
한의 표준임상진료지침 및 한의 표준임상경로에 대한 한의사의 인식
대한예방한의학회지
2022 .08
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2017-519-002365112